carboplatin

Related by string. Carboplatin * * carboplatin paclitaxel . paclitaxel carboplatin . cisplatin carboplatin . carboplatin AUC 6 . gemcitabine carboplatin . carboplatin AUC . carboplatin Taxol . chemotherapy carboplatin . carboplatin chemotherapy . chemotherapeutic agents carboplatin . Paclitaxel Carboplatin . Paraplatin ® carboplatin . Carboplatin Paclitaxel . ifosfamide carboplatin *

Related by context. All words. (Click for frequent words.) 79 docetaxel 78 gemcitabine 73 carboplatin paclitaxel 72 capecitabine 72 temozolomide 72 cetuximab 72 cisplatin 72 5 fluorouracil 71 docetaxel chemotherapy 71 bevacizumab 71 pemetrexed 71 FOLFOX 70 FOLFIRI 70 erlotinib 70 nab paclitaxel 69 dacarbazine 69 cytarabine 69 oxaliplatin 69 rituximab 69 Taxotere ® 69 gefitinib 69 Fludara 68 bortezomib 68 paclitaxel 68 pegylated liposomal doxorubicin 68 topotecan 68 Taxotere 68 gemcitabine chemotherapy 67 trastuzumab 67 5 FU 67 cyclophosphamide 67 leucovorin 67 Doxil ® 67 decitabine 67 mitoxantrone 67 vinorelbine 67 HER2 positive metastatic breast 67 paclitaxel carboplatin 67 lapatinib 66 irinotecan 66 plus dexamethasone 66 chemoradiation 66 sunitinib 66 monotherapy 66 chlorambucil 66 azathioprine 66 pomalidomide 66 fluorouracil 66 imatinib 66 Taxotere R 66 vandetanib 66 interferon alfa 2a 65 estramustine 65 chemotherapy regimens 65 chemoradiotherapy 65 mycophenolate mofetil 65 melphalan prednisone 65 lenalidomide 65 sorafenib Nexavar 65 platinum refractory 65 FOLFOX4 65 bendamustine 65 Carboplatin 65 neoadjuvant chemotherapy 65 gemcitabine carboplatin 65 resistant ovarian cancer 64 sorafenib 64 Gemcitabine 64 pegylated interferon alfa 2b 64 metastatic renal cell carcinoma 64 free survival PFS 64 sorafenib Nexavar ® 64 DMARDs 64 pegylated interferon 64 5FU 64 mcg kg 64 docetaxel Taxotere 64 zoledronic acid 64 aflibercept 64 adjuvant therapy 64 docetaxel Taxotere R 64 #mg/m# [002] 64 adriamycin 64 metastatic colorectal cancer 63 ixabepilone 63 relapsed ovarian cancer 63 advanced NSCLC 63 Platinol 63 pegylated interferon alfa 2a 63 dasatinib 63 paclitaxel chemotherapy 63 temsirolimus 63 Folfox 63 mitomycin 63 DOXIL 63 etoposide 63 lamivudine 63 #mg/m# [001] 63 relapsed CLL 63 Gemzar ® 63 daunorubicin 63 melphalan 63 mg m² 63 plus prednisone 63 doxorubicin cyclophosphamide 63 interferon alfa 63 low dose cytarabine 63 bevacizumab Avastin ® 63 peg IFN 63 mg/m2 63 mapatumumab 63 tenofovir emtricitabine 63 idarubicin 63 cytotoxic chemotherapy 62 CHOP chemotherapy 62 pertuzumab 62 gemcitabine Gemzar 62 5-FU/LV 62 chemotherapy cisplatin 62 nilotinib 62 adecatumumab 62 methotrexate 62 fluoropyrimidine 62 plus gemcitabine 62 doxorubicin 62 Peg IFN 62 Panzem R NCD 62 CA4P 62 neoadjuvant 62 letrozole 62 Cisplatin 62 taxane 62 standard chemotherapy regimen 62 fludarabine 62 BEACOPP 62 infusional 5-FU/LV 62 epirubicin 62 anti TNF 62 eribulin 62 FOLPI 62 trastuzumab Herceptin R 62 Irinotecan 62 adalimumab 62 REBETOL 62 adjuvant chemotherapy 62 cisplatin gemcitabine 62 chemotherapy docetaxel 62 chemotherapy regimen 62 dexamethasone Decadron 62 azacitidine 62 IMGN# 61 irinotecan chemotherapy 61 5 FU leucovorin 61 ribavirin RBV 61 trabectedin 61 taxane therapy 61 zalutumumab 61 Xeloda ® 61 FOLFOX6 61 recurrent GBM 61 neoadjuvant treatment 61 dose regimens 61 pazopanib 61 heavily pretreated 61 paclitaxel Taxol ® 61 Doxil 61 VELCADE melphalan 61 chemotherapies 61 plus ribavirin 61 iniparib 61 metastatic GIST 61 infliximab 61 pegylated interferon alpha 61 tolerability 61 heavily pretreated patients 61 TORISEL 61 dosing regimens 61 ELOXATIN 61 peginterferon alfa 2b 61 SCH # 61 PXD# 61 Docetaxel 61 5 fluorouracil leucovorin 61 bortezomib Velcade R 61 paclitaxel Taxol 61 ribavirin 61 paclitaxel cisplatin 61 Amrubicin 61 low dose dexamethasone 61 docetaxel Taxotere ® 61 lopinavir r 61 Copegus ribavirin 61 postoperative chemotherapy 61 active comparator 61 ritonavir boosted 61 YONDELIS 60 placebo dexamethasone 60 administered subcutaneously 60 Allovectin 7 ® 60 enzastaurin 60 alfa 2a 60 Pemetrexed 60 Cytoxan 60 mRCC 60 NSCLC 60 Pegasys ® 60 glufosfamide 60 Ixempra 60 boosted protease inhibitor 60 Xeloda capecitabine 60 alkylating agent 60 refractory NSCLC 60 axitinib 60 forodesine 60 oral clodronate 60 paclitaxel Taxol R 60 DMARD 60 Platinol ® cisplatin 60 chemotherapeutic agents 60 Bezielle 60 XELOX 60 cisplatin chemotherapy 60 VELCADE 60 NRTIs 60 metastatic HRPC 60 HGS ETR1 60 PREZISTA r 60 unresectable 60 oral deforolimus 60 Capecitabine 60 imetelstat 60 Vectibix 60 goserelin 60 Hycamtin 60 celgosivir 60 relapsed refractory multiple myeloma 60 TMC# [001] 60 locoregional 60 clodronate 60 seliciclib 60 remission induction 60 erlotinib Tarceva ® 60 liposomal doxorubicin 60 mg m 60 peginterferon 60 fallopian tube carcinoma 60 refractory multiple myeloma 60 perifosine 60 Alkeran 60 metastatic RCC 60 Imprime PGG 60 chemotherapeutic agent 60 comparator arm 60 custirsen 60 hormone refractory prostate cancer 60 Bortezomib 60 median PFS 60 peginterferon alfa 2a 60 bevacizumab Avastin 59 anastrozole 59 refractory AML 59 COPEGUS 59 antitumor activity 59 abacavir lamivudine 59 metastatic CRC 59 chemo radiotherapy 59 CANCIDAS 59 Paclitaxel 59 APTIVUS r 59 T DM1 59 etanercept 59 tocilizumab 59 capecitabine Xeloda 59 gemcitabine cisplatin 59 nitazoxanide 59 Targretin 59 Taxotere docetaxel 59 Lenalidomide 59 RAD# [003] 59 ERBITUX 59 standard chemotherapy regimens 59 dose cytarabine 59 INTELENCE 59 Sanofi Aventis Taxotere 59 dacarbazine DTIC 59 tanespimycin 59 interferon alfa 2b 59 CoFactor 59 peginterferon alfa 2a #KD 59 rilpivirine 59 REOLYSIN ® 59 biologic therapy 59 ACTEMRA TM 59 brain metastases 59 neoadjuvant therapy 59 raltegravir 59 taxanes 59 sapacitabine 59 dacarbazine chemotherapy 59 protease inhibitor PI 59 sunitinib malate 59 neratinib 59 Paraplatin ® 59 imatinib resistant 59 cilengitide 59 Tarceva TM 59 Xeloda 59 Ribavirin 59 Neoadjuvant 59 gefitinib Iressa 59 cabazitaxel 59 sorafenib tablets 59 evaluating tivozanib 59 capecitabine Xeloda R 59 TAXOTERE R 59 Fludara ® 59 evaluating Xcytrin 59 HRPC 59 mg BID 59 olaparib 59 telaprevir dosed 59 metastatic hormone refractory 59 dexamethasone 59 follicular NHL 59 chemotherapeutic regimens 59 epirubicin cyclophosphamide 59 saline placebo 59 TACE 59 picoplatin 59 metastatic colorectal carcinoma 58 oblimersen 58 Genasense 58 docetaxel prednisone 58 FOLFIRINOX 58 xenograft models 58 irbesartan 58 panitumumab 58 satraplatin 58 cyclophosphamide doxorubicin vincristine 58 progression TTP 58 q8h 58 lenalidomide dexamethasone 58 darunavir ritonavir 58 Tarceva 58 randomized Phase III 58 YERVOY 58 chemotherapy 58 Gemzar 58 dose cohorts 58 mcg albinterferon alfa 2b 58 afatinib 58 CIMZIA TM 58 HER2 negative 58 recurrent NSCLC 58 overlapping toxicities 58 REVLIMID ® 58 mg qd 58 EFAPROXYN 58 cytogenetic response 58 TYKERB 58 8mg/kg 58 FOLFOX4 alone 58 exemestane 58 concurrent chemoradiation 58 chemotherapy FOLFOX 58 tamoxifen 58 taxane chemotherapy 58 KRAS mutations occur 58 3TC 58 APTIVUS 58 Taxol ® 58 dasatinib Sprycel 58 FOLPI regimen 58 FOLFIRI alone 58 ofatumumab 58 mcg dose 58 Taxotere chemotherapy 58 anthracycline taxane 58 TELCYTA 58 Gefitinib 58 Peginterferon 58 imatinib therapy 58 Pegasys peginterferon alfa 2a 58 gastrointestinal stromal tumor GIST 58 amrubicin 58 abiraterone acetate 58 dose escalation 58 ibandronate 58 paclitaxel poliglumex 58 rituximab Rituxan 58 peginterferon alfa 2a Pegasys 58 phase IIb clinical 58 relapsed refractory 58 LEXIVA r 58 Chemophase 58 ELACYT 58 Herceptin trastuzumab 58 Topotecan 58 interferon ribavirin 58 PEGINTRON 58 atazanavir 58 FOLFOX regimen 58 5 Fluorouracil 58 HGS# 58 Tarceva erlotinib 58 Ph + ALL 58 cyclophosphamide methotrexate 58 Lapatinib 58 FOLFOX6 chemotherapy regimen 58 vorinostat 58 surrogate endpoint 58 MGd 58 PegIFN RBV 58 ABVD 58 huN# DM1 58 fulvestrant 58 mg/m2 dose 58 interferon gamma 1b 58 cytarabine daunorubicin 58 refractory CTCL 58 palifosfamide 58 irinotecan doxorubicin oxaliplatin paclitaxel 58 imatinib Gleevec 58 dosing schedules 58 recurrent ovarian cancer 58 lapatinib Tykerb 58 mitoxantrone chemotherapy 58 Jevtana 58 oral rivaroxaban 58 vandetanib #mg 58 evaluable 58 pegylated interferon alpha 2a 58 piperacillin tazobactam 58 SPRYCEL 58 TNF inhibitor 58 valopicitabine 57 dasatinib Sprycel ® 57 anti leukemic 57 fluconazole 57 peginterferon alfa 57 Reolysin 57 eribulin mesylate 57 teriflunomide 57 neurologic progression 57 Taxol paclitaxel 57 Free Survival PFS 57 ceftriaxone 57 Fludarabine 57 cetuximab Erbitux R 57 PegIntron 57 q#h 57 pegylated interferon alfa 57 refractory cutaneous T 57 chemotherapy gemcitabine 57 doublet chemotherapy 57 glioblastoma multiforme GBM 57 cell lymphoma CTCL 57 isoniazid 57 Camptosar ® 57 administered orally 57 mCRC 57 LY# [003] 57 PEG interferon 57 Paraplatin ® carboplatin 57 telaprevir dosing 57 romidepsin 57 Oxaliplatin 57 fluticasone 57 mg QD 57 visilizumab 57 Ceplene/IL-2 57 alvespimycin 57 FOLFOX chemotherapy 57 evaluable patients 57 Pegasys plus Copegus 57 galiximab 57 fluorouracil leucovorin 57 lopinavir ritonavir 57 LPV r 57 Dasatinib 57 4mg/kg 57 cisplatin vinorelbine 57 vicriviroc 57 Trastuzumab 57 chemotherapeutic regimen 57 OPAXIO 57 Tykerb 57 ZACTIMA 57 temozolomide TMZ 57 dose dexamethasone 57 patients receiving ERBITUX 57 anthracyclines taxanes 57 TELINTRA 57 idraparinux 57 Pegasys R 57 Erlotinib 57 Aptivus ® 57 mg kg dose 57 ritonavir boosted atazanavir 57 tesmilifene 57 cutaneous T cell 57 oxycodone CR 57 INCB# [001] 57 bone metastases 57 Platinol ® 57 OncoVEX GM CSF 57 chemoradiation therapy 57 GRN#L 57 FluCAM 57 gemcitabine Gemzar ® 57 protease inhibitor 57 unresectable locally advanced 57 glatiramer acetate 57 infliximab monotherapy 57 TTF Therapy 57 chemotherapeutic drug 57 bortezomib Velcade 57 RG# [001] 57 unresectable stage 57 elotuzumab 57 metastatic castration resistant 57 NNRTI 57 cisplatin carboplatin 57 Torisel 57 Halaven 57 octreotide LAR 57 KRAS status 57 BAY #-# 57 beclomethasone dipropionate 57 alpha 2a 57 interferon 57 relapsing multiple sclerosis 57 CIMZIA ™ 57 nucleoside analogue 57 peginterferon alpha 2a 57 patients evaluable 57 #mg BID [003] 57 EGFR expressing mCRC 57 recurrent glioblastoma multiforme 57 brentuximab vedotin 57 squamous histology 57 adjuvant radiation 57 leukemia CLL 57 fallopian tube cancers 57 Laquinimod 57 adalimumab Humira 57 tumor shrinkage 57 mCi kg 57 radiation chemoradiation 57 sustained virologic response 57 prednisone prednisolone 57 certolizumab 57 mg/m2/day 57 dose regimen 57 viral kinetics 57 intravenous bisphosphonates 57 plus prednisone prednisolone 57 ZOLINZA 57 cyclophosphamide chemotherapy 57 follicular lymphoma 57 Q2W 57 alkylating agents 56 tolerability profile 56 DMARD therapy 56 Bevacizumab 56 FUSILEV enhances 56 Genasense ® 56 Median survival 56 pegfilgrastim 56 systemic ALCL 56 Pegylated Interferon 56 EOquin TM 56 Mitoxantrone 56 MIRCERA 56 PEGINTRON TM 56 mitoxantrone plus 56 mg/m2 administered 56 fondaparinux 56 rifampin 56 prostate cancer HRPC 56 μg dose 56 cetuximab Erbitux ® 56 CAELYX 56 aflibercept VEGF Trap 56 allopurinol 56 ALIMTA 56 mg dose 56 vincristine 56 ISENTRESS 56 indolent NHL 56 LIALDA 56 rifapentine 56 unfractionated heparin 56 lenalidomide Revlimid R 56 relapsed SCLC 56 ascending dose 56 ganetespib 56 folinic acid FA 56 subcutaneous SC 56 evaluating ispinesib 56 refractory chronic lymphocytic 56 viral kinetic 56 ANA# 56 GnRH agonists 56 tacrolimus ointment 56 cetuximab Erbitux 56 adjuvant 56 CCyR 56 stage IIIB 56 tipranavir 56 achieved ACR# 56 levofloxacin 56 oral diclofenac 56 abiraterone 56 REVLIMID 56 MAGE A3 ASCI 56 PKC# 56 adjuvant cisplatin 56 pyrazinamide 56 lymphoma CTCL 56 mg/m2 IV 56 subcutaneously administered 56 TNFerade 56 Neulasta ® 56 FIRMAGON 56 Nexavar 56 MGCD# [002] 56 AVASTIN 56 plus COPEGUS 56 enfuvirtide 56 R# #mg BID 56 superficial bladder cancer 56 Cloretazine 56 Aromasin 56 trabedersen 56 VIDAZA 56 Traficet EN 56 stavudine 56 recurrent malignant glioma 56 tipranavir r 56 mg ustekinumab 56 relapsed MM 56 AP# [003] 56 subcutaneous injections 56 taxotere 56 placebo 56 adefovir 56 INC# 56 IMC A# 56 tamoxifen therapy 56 receiving INTRON 56 infusional 56 posaconazole 56 mg RDEA# 56 chronic lymphocytic leukemia CLL 56 Voreloxin 56 SCCHN 56 Vidaza ® 56 TEMODAL 56 Phase Ib 56 interferon alpha 56 AVONEX ® 56 insulin glargine 56 PREZISTA rtv 56 flutamide 56 relapsed myeloma 56 metastatic melanoma 56 entinostat 56 metastatic breast cancer 56 darunavir 56 NRTI 56 epirubicin cisplatin 56 GEMZAR 56 Velcade bortezomib 56 bevacizumab Avastin R 56 Vincristine 56 rFSH 56 farletuzumab 56 ceftazidime 56 Epirubicin 56 CIMZIA TM certolizumab pegol 56 immunomodulatory therapy 56 intermittent dosing 56 partial remissions 56 injected subcutaneously 56 methotrexate MTX 56 tamsulosin 56 carboplatin chemotherapy 56 crizotinib PF # 56 PegIFN 56 Femara letrozole 56 dosage regimens 56 Hycamtin ® 56 REVLIMID R 56 tiotropium bromide 56 metformin 56 metaglidasen 56 liver metastases 56 EndoTAGTM 1 56 budesonide 56 ZYBRESTAT 56 refractory ovarian cancer 56 dosing intervals 56 glargine 56 histone deacetylase HDAC inhibitor 56 hormonal therapy 56 Toxicities 56 bleomycin 56 REYATAZ R 56 papillary renal cell carcinoma 56 Flu Cy 56 panitumumab Vectibix 56 zoledronate 56 Cetuximab 56 Femara 56 Dacogen injection 56 stage IIIb IV 55 preoperative chemotherapy 55 uric acid lowering 55 intramuscular injections 55 TO AVOID PREGNANCY WHILE 55 Etoposide 55 EGFR TKI 55 comparator PI r 55 aromatase inhibitor 55 metastatic NSCLC 55 naïve HCV 55 dabigatran etexilate 55 pegylated interferons 55 bosutinib 55 relapsed multiple myeloma 55 DMARDS 55 GnRH agonist 55 advanced unresectable 55 Epivir 55 Aflibercept 55 Pegintron 55 Rituxan 55 pharmacologically active isomer 55 external beam radiotherapy 55 nucleoside reverse transcriptase inhibitor 55 folinic acid 55 virologic failure 55 HCV SPRINT 55 Navelbine 55 telaprevir 55 ribavirin therapy 55 metastatic malignant 55 nilotinib Tasigna ® 55 bicalutamide 55 sorafenib Nexavar R 55 luteinizing hormone releasing 55 plus 5-FU/LV 55 belinostat 55 REOLYSIN R 55 pharmacodynamic properties 55 IRESSA 55 advanced hepatocellular carcinoma 55 vinca alkaloid 55 clopidogrel Plavix 55 alendronate 55 mg subcutaneously 55 cediranib 55 HspE7 55 REVLIMID lenalidomide 55 oral allopurinol 55 imiquimod 55 micafungin 55 XGEVA 55 Glufosfamide 55 doxorubicin HCl liposome injection 55 ipilimumab 55 elacytarabine 55 ER CHOP 55 bivalirudin 55 albinterferon alfa 2b 55 VICTRELIS 55 Navelbine ® 55 subcutaneous doses 55 febuxostat 55 peg interferon 55 splenectomized patients 55 cobicistat 55 complete cytogenetic 55 ascending doses 55 disease modifying antirheumatic 55 tiotropium 55 nucleoside reverse transcriptase inhibitors 55 eculizumab 55 amoxicillin clavulanate 55 cyclophosphamide Cytoxan 55 etravirine 55 relapsing MS 55 Pharmacokinetics PK 55 Phase Ib II 55 IV bolus 55 antiretroviral agents 55 sunitinib Sutent 55 achieved sustained virologic 55 oral antiviral 55 EBRT 55 Cloretazine R VNP#M 55 maximally tolerated dose 55 hA# 55 Median progression 55 interferon beta therapy 55 recurrent metastatic 55 pioglitazone 55 nucleoside analogs 55 thymalfasin 55 sertraline 55 sunitinib Sutent ® 55 Hazard Ratio 55 non squamous NSCLC 55 HBeAg seroconversion 55 voreloxin 55 lamivudine 3TC 55 PROSTVAC ® 55 pegylated interferon peg IFN 55 caspofungin 55 Xcytrin 55 thalidomide Thalomid 55 administered intravenously 55 intravenous REOLYSIN 55 diagnosed multiple myeloma 55 Gemzar gemcitabine 55 gp# vaccine 55 imipenem 55 ABRAXANE 55 refractory CLL 55 interferon beta 1a 55 HGS ETR2 55 oxaliplatin Eloxatin 55 Abraxane 55 entecavir 55 refractory metastatic 55 CYT# 55 androgen independent 55 metastatic renal cell 55 dutasteride 55 oral ridaforolimus 55 Anti TNF 55 milatuzumab 55 subcutaneous formulation 55 androgen deprivation 55 GVAX 55 DTIC 55 PEG INTRON 55 pCR 55 Gleevec resistant 55 regorafenib 55 TNF antagonists 55 radiochemotherapy 55 adjuvant tamoxifen 55 Velcade 55 azacytidine 55 darbepoetin alfa 55 TREANDA 55 RECIST criteria 55 locoregional recurrence 55 doxorubicin docetaxel 55 Cyclophosphamide 55 Golimumab 55 AGILECT R 55 ponatinib 55 stavudine d4T 55 Triapine 55 SPRYCEL ® 55 TRIZIVIR 55 IMiDs 55 BRIM2 55 vancomycin 55 teriparatide 55 tacrolimus 55 Adjuvant chemotherapy 55 ethambutol 54 FOLFIRI chemotherapy 54 HBeAg positive patients 54 ALA PDT 54 Cloretazine ® 54 moxifloxacin 54 complete cytogenetic response 54 Treanda 54 daily Infergen 54 DAVANAT 54 abatacept 54 hepatic metastases 54 eniluracil 54 resected pancreatic cancer 54 FOLOTYN 54 Tavocept 54 mCRC patients 54 Metastatic Colorectal Cancer 54 metastatic HER2 negative 54 CLARITY study 54 PEG IFN 54 Sandostatin R 54 Elitek 54 iniparib BSI 54 Revlimid lenalidomide 54 IIIa inhibitor 54 q# 54 sulfasalazine 54 depsipeptide 54 ASA# 54 vinca alkaloids 54 pancreatic NET 54 baminercept 54 biologic DMARD 54 bortezomib refractory 54 antiandrogen 54 advanced metastatic renal 54 taxane refractory 54 Peginterferon alfa 2b 54 HER2 positive breast cancer 54 pemetrexed Alimta 54 trans retinoic acid ATRA 54 leukemia AML 54 bisphosphonate 54 PREZISTA ritonavir 54 HuMax CD4 54 relapsed 54 Omnitarg 54 eltrombopag 54 ProLindac 54 mg TID 54 R sorafenib tablets 54 Eloxatin R 54 oral levofloxacin 54 SUTENT 54 Elotuzumab 54 angiogenesis inhibitor 54 Tasigna nilotinib 54 refractory metastatic colorectal cancer 54 letrozole Femara 54 risedronate 54 linezolid 54 Newly Diagnosed Multiple Myeloma 54 evaluating picoplatin 54 PEG SN# 54 bosentan 54 solid tumors 54 Camptosar 54 Fluorouracil 54 pancreatic adenocarcinoma 54 tirofiban 54 chemoembolization 54 cytogenetic responses 54 PEG Intron 54 AEG# 54 abciximab 54 Tamibarotene 54 PEG Interferon lambda 54 immunomodulator 54 trans retinoic acid 54 VNP#M 54 Sandostatin LAR Depot 54 dose escalation trial 54 ONCASPAR 54 KRAS wild 54 PROMACTA 54 cytokine refractory 54 thienopyridine 54 plus methotrexate 54 Telintra 54 KRN# 54 SCIg 54 prednisone CHOP 54 MabCampath 54 REMICADE ® 54 Nexavar ® 54 xanthine oxidase inhibitor 54 Pertuzumab 54 ZADAXIN 54 CLORETAZINE TM VNP#M 54 febrile neutropenia 54 rivaroxaban 54 palonosetron 54 valsartan 54 temsirolimus Torisel ® 54 cytotoxic agents 54 nelfinavir 54 clopidogrel 54 insulin detemir 54 CR# vcMMAE 54 dose cohort 54 randomized #:# 54 mesalamine 54 tiuxetan 54 desvenlafaxine succinate 54 efavirenz EFV 54 Rituximab 54 Gleevec imatinib 54 Mylotarg 54 oral chemotherapeutic agent 54 HCV RESPOND 2 54 Taxol 54 PSMA ADC 54 fluticasone salmeterol

Back to home page